For the first time, AI has been used to design bacteriophages (viruses that infect bacteria) capable of targeting and destroying antibiotic-resistant strains of Escherichia coli in laboratory conditions. The approach involves generating novel phage structures with specific binding sites tailored to resist bacterial defense mechanisms. While promising, this is still in the preclinical stage, and further studies are needed to assess safety and efficacy in human trials.
About the Author
